Novo Ramps Up Prandin IP Battle With Sandoz Suit
Novo Nordisk A/S filed suit Friday in New Jersey aiming to block Sandoz Inc.'s generic version of diabetes treatment Prandin, the latest broadside in an ongoing feud with generic-drug makers over...To view the full article, register now.
Already a subscriber? Click here to view full article